Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)
ACCQUIREnet
1 other identifier
observational
1,000
2 countries
11
Brief Summary
The Allied Cleft \& Craniofacial Quality-Improvement and Research Network (ACCQUIREnet) is a group of multidisciplinary cleft teams that have implemented a system for prospective collection of outcomes data, based on the ICHOM Standard Set for the Comprehensive Appraisal of Cleft Care, CLEFT-Q, and other outcomes instruments. Participating cleft teams may analyze clinical and psychosocial outcomes related to care of the child with cleft lip and/or palate (CL/P), compare its performance with those of other cleft centers, and identify opportunities for quality improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2015
CompletedFirst Posted
Study publicly available on registry
March 9, 2016
CompletedStudy Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2031
January 7, 2026
January 1, 2026
15.2 years
October 16, 2015
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (45)
Speech: intelligibility
Utilizes the intelligibility in context scale (ICS)
~5 years of age
Speech: intelligibility
Utilizes the intelligibility in context scale (ICS)
~8 years of age
Speech: intelligibility
Utilizes the intelligibility in context scale (ICS)
~12 years of age
Speech: intelligibility
Utilizes the intelligibility in context scale (ICS)
~22 years of age
Speech: velopharyngeal competence
~5 years of age
Speech: velopharyngeal competence
~8 years of age
Speech: velopharyngeal competence
~12 years of age
Speech: velopharyngeal competence
~22 years of age
Speech: articulation
Utilizes the modified percent correct consonants (mPCC) scale
~5 years of age
Speech: articulation
Utilizes the modified percent correct consonants (mPCC) scale
~8 years of age
Speech: articulation
Utilizes the modified percent correct consonants (mPCC) scale
~12 years of age
Speech: articulation
Utilizes the modified percent correct consonants (mPCC) scale
~22 years of age
Speech: patient-reported outcomes related to speech and speaking
Utilizes the CLEFT-Q PROM
~8 years of age
Speech: patient-reported outcomes related to speech and speaking
Utilizes the CLEFT-Q PROM
~12 years of age
Speech: patient-reported outcomes related to speech and speaking
Utilizes the CLEFT-Q PROM
~22 years of age
Hearing: puretone average
~5 years of age
Dental: dmft and DMFT scores
Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth
~5 years of age
Dental: dmft and DMFT scores
Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth
~12 years of age
Dental: dmft and DMFT scores
Utilizes the dmft score for deciduous teeth and DMFT score for permanent teeth
~22 years of age
Dental: occlusion (Uses modifications of the GOSLON scale)
~5 years of age
Dental: occlusion (Uses modifications of the Bauru scale)
~5 years of age
Dental: occlusion (Uses modifications of the GOSLON scale)
~12 years of age
Dental: occlusion (Uses modifications of the Bauru scale)
~12 years of age
Dental: occlusion (Uses modifications of the GOSLON scale)
~22 years of age
Dental: occlusion (Uses modifications of the Bauru scale)
~22 years of age
Dental: patient-reported outcomes related to mastication
Uses the CLEFT-Q PROM
~8 years of age
Dental: patient-reported outcomes related to mastication
Uses the CLEFT-Q PROM
~12 years of age
Dental: patient-reported outcomes related to mastication
Uses the CLEFT-Q PROM
~22 years of age
Dental: patient-reported outcomes related to oral health
Uses the COHIP PROM
~8 years of age
Dental: patient-reported outcomes related to oral health
Uses the COHIP PROM
~12 years of age
Dental: patient-reported outcomes related to oral health
Uses the COHIP PROM
~22 years of age
Patient-reported outcomes related to eating/drinking
Uses the CLEFT-Q PROM
~8 years of age
Patient-reported outcomes related to eating/drinking
Uses the CLEFT-Q PROM
~12 years of age
Patient-reported outcomes related to eating/drinking
Uses the CLEFT-Q PROM
~22 years of age
Breathing: Patient-reported outcomes related to nasal and oral breathing
Uses the NOSE PROM
~8 years of age
Breathing: Patient-reported outcomes related to nasal and oral breathing
Uses the NOSE PROM
~12 years of age
Breathing: Patient-reported outcomes related to nasal and oral breathing
Uses the NOSE PROM
~22 years of age
Aesthetics: Patient-reported outcomes related to appearance
Uses the CLEFT-Q PROM
~8 years of age
Aesthetics: Patient-reported outcomes related to appearance
Uses the CLEFT-Q PROM
~12 years of age
Aesthetics: Patient-reported outcomes related to appearance
Uses the CLEFT-Q PROM
~22 years of age
Aesthetics: Clinical assessment of nasolabial and facial aesthetics
~2 years of age
Aesthetics: Clinical assessment of nasolabial and facial aesthetics
~5 years of age
Aesthetics: Clinical assessment of nasolabial and facial aesthetics
~8 years of age
Aesthetics: Clinical assessment of nasolabial and facial aesthetics
~12 years of age
Aesthetics: Clinical assessment of nasolabial and facial aesthetics
~22 years of age
Study Arms (5)
uCL(A)
Children with unilateral cleft lip with/without cleft alveolus but intact secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form).
uCL(A)P
Children with unilateral cleft lip with/without cleft alveolus and with cleft secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form) and severity of palate (submucous, Veau-I, Veau-II, or Veau-III).
bCL(A)
Children with bilateral cleft lip with/without cleft alveolus but intact secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form).
bCL(A)P
Children with unilateral cleft lip with/without cleft alveolus and with cleft secondary palate. Subgroup analysis by severity of lip (complete, incomplete, or lesser-form) and severity of palate (submucous, Veau-I, Veau-II, Veau-III, or Veau-IV).
CP
Children with cleft secondary palate only, but intact lip and alveolus. Subgroup analysis by severity (submucous, Veau-I, or Veau-II).
Interventions
Eligibility Criteria
All patients born with cleft lip and/or palate are eligible for inclusion in this study.
You may qualify if:
- Typical orofacial clefts, of which subtypes are:
- Unilateral or bilateral cleft lip
- Unilateral or bilateral cleft lip and alveolus
- Unilateral or bilateral cleft lip and alveolus and palate
- Unilateral or bilateral cleft lip and palate
- Overt cleft palate
- Occult cleft palate
You may not qualify if:
- Atypical (Tessier) facial clefts
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (11)
University of Florida - Shands Hospital
Gainesville, Florida, 32608, United States
Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021, United States
Orlando Health - Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
Johns Hopkins - All Children's Hospital (JHACH)
St. Petersburg, Florida, 33701, United States
Maine Medical Center
Portland, Maine, 04102, United States
Harvard University - Boston Children's Hospital (BCH)
Boston, Massachusetts, 02115, United States
Washington University - St. Louis Children's Hospital (WUSTL)
St Louis, Missouri, 63110, United States
Duke University - Duke Children's Hospital & Health Center
Durham, North Carolina, 27710, United States
Wake Forest University - Brenner Children's Hospital
Winston-Salem, North Carolina, 27157, United States
University of Texas at Houston - Children's Memorial Hermann Hospital
Houston, Texas, 77030, United States
Dalhousie University - IWK Health Centre
Halifax, Nova Scotia, B3K 6R8, Canada
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander C Allori, MD, MPH
Duke University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 22 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2015
First Posted
March 9, 2016
Study Start
October 1, 2016
Primary Completion (Estimated)
December 1, 2031
Study Completion (Estimated)
December 1, 2031
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
This is a collaborative research network. All data processing happens at the coordinating center, with results reviewed by the participating centers.